Retrospective definition of reaction risk in Italian children with peanut, hazelnut and walnut allergy through component-resolved diagnosis*

Main Article Content

M. Giovannini
P. Comberiati
M. Piazza
E. Chiesa
G.L. Piacentini
A. Boner
G. Zanoni
D.G. Peroni

Keywords

Peanut allergy, Hazelnut allergy, Walnut allergy, Children, Specific IgE, Component-resolved diagnostics

Abstract

Background: Serum IgE evaluation of peanut, hazelnut and walnut allergens through the use of component-resolved diagnosis (CRD) can be more accurate than IgE against whole food to associate with severe or mild reactions.


Objectives: The aim of the study was to retrospectively define the level of reaction risk in children with peanut, hazelnut and walnut sensitization through the use of CRD.


Methods: 34 patients [n = 22 males, 65%; median age eight years, interquartile range (IQR) 5.0-11.0 years] with a reported history of reactions to peanut and/or hazelnut and/or walnut had their serum analyzed for specific IgE (s-IgE) by ImmunoCAP® and ISAC® microarray technique.


Results: In children with previous reactions to peanut, the positivity of Arah1 and Arah2 s-IgE was associated with a history of anaphylaxis to such food, while the positivity of Arah8 s-IgE were associated with mild reactions. Regarding hazelnut, the presence of positive Cora9 and, particularly, Cora14 s-IgE was associated with a history of anaphylaxis, while positive Cora1.0401 s-IgE were associated with mild reactions. Concerning walnut, the presence of positive Jug r 1, Jug r 2, Jug r 3 s-IgE was associated with a history of anaphylaxis to such food. ImmmunoCAP® proved to be more useful in retrospectively defining the risk of hazelnut anaphylaxis, because of the possibility of measuring Cor a14 s-IgE.


Conclusions: Our data show that the use of CRD in patients with allergy to peanut, hazelnut and walnut could allow for greater accuracy in retrospectively defining the risk of anaphylactic reaction to such foods.

Abstract 390 | PDF Downloads 303

References

1. Prescott SL, Pawankar R, Allen KJ, Campbell DE, Sinn JKH, Fiocchi A, et al. A global survey of changing patterns of food allergy burden in children. World Allergy Organ J. 2013;6:21.

2. O’Keefe AW, De Schryver S, Mill J, Mill C, Dery A, Ben-Shoshan M. Diagnosis and management of food allergies: new and emerging options, a systematic review. J Asthma Allergy. 2014;24:141-64.

3. Sicherer SH, Sampson H. Food allergy. J Allergy Clin Immunol. 2010;125 Suppl. 2:S116-25.

4. Sicherer SH, Wood RA. Allergy testing in childhood: using allergen-specific IgE tests. Pediatrics. 2012;129:193-7.

5. Calamelli E, Caffarelli C, Ricci G. Peanut sensitization profiles in Italian children and adolescents with specific IgE to peanuts. Biomed Res Int. 2013;2013:170452.

6. Sastre J. Molecular diagnosis in allergy. Clin Exp Allergy. 2010;40:1442-60.

7. Lidholm J, Ballmer-Weber BK, Mari A, Vieths S. Componentresolved diagnostics in food allergy. Curr Opin Allergy Clin Immunol. 2006;6:234-40.

8. Hakimeh D, Tripodi S. Recent advances on diagnosis and management of childhood asthma and food allergies. Ital J Pediatr. 2013;39:80.

9. Wolthers OD. Component-resolved diagnosis in pediatrics. ISRN Pediatr. 2012;2012:806920.

10. Astier C, Morisset M, Roitel O, Codreanu F, Jacquenet S, Franck P, et al. Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy. J Allergy Clin Immunol. 2006;118:250-6.

11. Renz H. Advances in in vitro diagnostics in allergy, asthma, and immunology in 2012. J Allergy Clin Immunol. 2013;132:1287-92.

12. Lin YT, Wu CT, Cheng JH, Huang JL, Yeh KW. Patterns of sensitization to peanut allergen components in Taiwanese Preschool children. J Microbiol Immunol Infect. 2012;45:90-5.

13. Agabriel C, Ghazouani O, Birnbaum J, Liabeuf V, Porri F, Gouitaa M, et al. Ara h 2 and Ara h 6 sensitization predicts peanut allergy in Mediterranean pediatric patients. Pediatr Allergy Immunol. 2014;25:662-7.

14. Kim J, Lee JY, Han Y, Ahn K. Significance of Ara h 2 in clinical reactivity and effect of cooking methods on allergenicity. Ann
Allergy Asthma Immunol. 2013;110:34-8.

15. Nicolaou N, Custovic A. Molecular diagnosis of peanut and legume allergy. Curr Opin Allergy Clin Immunol. 2011;11:222-8.

16. Asarnoj A, Nilsson C, Lidholm J, Glaumann S, Östblom E, Hedlin G, et al. Peanut component Ara h 8 sensitization and tolerance to peanut. J Allergy Clin Immunol. 2012;130:468-72.

17. Glaumann S, Nopp A, Johansson SGO, Rudengren M, Borres MP, Nilsson C. Basophil allergen threshold sensitivity, CD-sens IgEsensitization and DBPCFC in peanut-sensitized children. Allergy. 2012;67:242-7.

18. Vereda A, van Hage M, Ahlstedt S, Ibanez ˜ MD, Cuesta-Herranz J, van Odijk J, et al. Peanut allergy: clinical and immunologic differences among patients from 3 different geographic regions. J Allergy Clin Immunol. 2011;127:603-7.

19. Flinterman AE, Akkerdaas JH, Knulst AC, van Ree R, Pasmans SG. Hazelnut allergy: from pollen-associated mild allergy to severe anaphylactic reactions. Curr Opin Allergy Clin Immunol. 2008;8:261-5.

20. Masthoff LJN, Mattsson L, Zuidmeer-Jongejan L, Lidholm J, Andersson K, Akkerdaas JH, et al. Sensitization to Cor a 9 and Cor a 14 is highly specific for a hazelnut allergy with objective symptoms in Dutch children and adults. J Allergy Clin Immunol. 2013;132:393-9.

21. Kattan JD, Sicherer SH, Sampson HA. Clinical reactivity to hazelnut may be better identified by component testing than traditional testing methods. J Allergy Clin Immunol Pract. 2014;2:633-4, e1.

22. Eller E, Mortz CG, Bindslev-Jensen C. Cor a 14 is the superior serological marker for hazelnut allergy in children, independent of concomitant peanut allergy. Allergy. 2016;71:556-62.

23. Faber MA, De Graag M, Van Der Heijden C, Sabato V, Hagendorens MM, Bridts CH, et al. Cor a 14: missing link in the molecular diagnosis of hazelnut allergy? Int Arch Allergy Immunol. 2014;164:200-6.

24. Roux K, Teuber HS, Sathe SSK. Tree nut allergens. Int Arch Allergy Immunol. 2003;131:234-44.